HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VOC reactivity program for antiperspirants/deodorants under consideration by California.

This article was originally published in The Rose Sheet

Executive Summary

CALIFORNIA "CLEAR" REACTIVITY VOC STANDARDS UNDER CONSIDERATION by the California Air Resource Board as an alternative volatile organic compound (VOC) reduction program for antiperspirants and deodorants. Currently, personal care companies are required to limit VOC emissions by weight and not by measurement of chemical reactivity. California's antiperspirant/deodorant VOC reg, slated to take effect Jan. 1, 1999, establishes a high volatile organic compound (HVOC) limit of 0% for aerosol products and a medium volatile organic compound limit (MVOC) not to exceed 10% by weight. Under the rule, antiperspirants and deodorants containing ethanol or fragrances or having a low vapor pressure (LVP) of 2 mmHg or less at 20C are exempt from the MVOC standard.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel